Cite
Corrigendum to "Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours" [Eur J Cancer 188 (2023) 39-48].
MLA
Hernando, Jorge, et al. “Corrigendum to ‘Sex Differences on Multikinase Inhibitors Toxicity in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumours’ [Eur J Cancer 188 (2023) 39-48].” European Journal of Cancer (Oxford, England : 1990), vol. 203, May 2024, p. 114061. EBSCOhost, https://doi.org/10.1016/j.ejca.2024.114061.
APA
Hernando, J., Roca-Herrera, M., García-Álvarez, A., Raymond, E., Ruszniewski, P., Kulke, M. H., Grande, E., Carbonero, R. G., Castellano, D., Salazar, R., Ibrahim, T., Teule, A., Alonso, V., Fazio, N., Valle, J. W., Tafuto, S., Carmona, A., Navarro, V., & Capdevila, J. (2024). Corrigendum to “Sex differences on multikinase inhibitors toxicity in patients with advanced gastroenteropancreatic neuroendocrine tumours” [Eur J Cancer 188 (2023) 39-48]. European Journal of Cancer (Oxford, England : 1990), 203, 114061. https://doi.org/10.1016/j.ejca.2024.114061
Chicago
Hernando, Jorge, Maria Roca-Herrera, Alejandro García-Álvarez, Eric Raymond, Philippe Ruszniewski, Matthew H Kulke, Enrique Grande, et al. 2024. “Corrigendum to ‘Sex Differences on Multikinase Inhibitors Toxicity in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumours’ [Eur J Cancer 188 (2023) 39-48].” European Journal of Cancer (Oxford, England : 1990) 203 (May): 114061. doi:10.1016/j.ejca.2024.114061.